Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Is Eli Lilly and Company LLY the Best Non-Tech Stock to Buy Now for Long Term?

February 23, 2025
Eli Lilly and Company (LLY) has been making waves in the investment world with its recent performance, attracting the attention of investors. As one of the leading pharmaceutical companies, Eli Lilly has been consistently focused on developing innovative drugs and therapies to improve the health and well-being of people worldwide.

Recently, Eli Lilly announced its participation in the TD Cowens 45th Annual Health Care Conference, which further showcased its commitment to staying at the forefront of the healthcare industry. This conference provides a platform for the company to share its latest developments, engage with industry experts, and explore potential collaborations.

Being a non-tech stock, Eli Lilly offers a unique investment opportunity for those looking for diversification in their portfolio. The company has a strong track record of delivering solid financial performance, with consistent revenue growth and robust profitability. With its strong pipeline of new products and ongoing efforts in research and development, Eli Lilly is well-positioned for long-term growth.

However, before making any investment decisions, it is always recommended to seek professional advice. Stocks Prognosis, a leading provider of stock market insights, can provide valuable guidance on the future movement of Eli Lilly's shares. Their team of experts analyzes market trends, company fundamentals, and other crucial factors to offer informed predictions.

In conclusion, Eli Lilly and Company (LLY) is attracting investor attention for its remarkable performance and commitment to driving innovation in the healthcare industry. As a non-tech stock, it presents a unique investment opportunity for long-term growth. To make well-informed investment decisions and stay ahead of the market, it is advisable to consult professionals like Stocks Prognosis.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 8, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast with Profit of 18.31%  ~1 min.

ELI LILLY AND COMPANY stock has successfully achieved the price target forecast set by QuantWave with a profit of 18.31%. The forecast, which indicated a short position on June 4, 2025, at a price of 764....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast as QuantWave Users Gain 17.38% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved the price target forecast set by QuantWave, marking a significant success for users of the automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Profit of 23.55%: A Success Story for QuantWave  ~2 min.

ELI LILLY AND COMPANY, a prominent player in the pharmaceutical industry, recently achieved a significant milestone by hitting a price target forecast generated by the innovative forecasting platform, QuantWave. The forecast, which indicated a short direction signal on April 17, 2025, at a price of 836.4 USD, proved to be accurate as the stock reached the predicted target price of 639.46 USD on Au...


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecast Price Target with 22.13% Profit - QuantWave Achieves Success in Stock Prediction  ~2 min.

ELI LILLY AND COMPANY stock recently reached the forecast price target set by QuantWave, resulting in a profit of 22.13%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast, Generating 17.25% Profit  ~1 min.

ELI LILLY AND COMPANY stock has successfully achieved the price target forecast set by QuantWave, reaching a profit of 17.25%. The forecast signal was issued on April 30, 2024, with the stock price at $772....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Short Price Target Forecast with 19.15% Profit  ~1 min.

On December 24, 2024, QuantWave, the automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was priced at 790.94 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 22.51% Profit for QuantWave Users  ~2 min.

ELI LILLY AND COMPANY, a prominent pharmaceutical company, recently achieved the price target forecast set by QuantWave, an automated forecasting platform, resulting in a profitable outcome for investors. The forecast signal was generated on 8th November 2024 when the stock was priced at 825.23 $. The prediction indicated a short direction, and on 7th August 2025, the target price of 639.46 $ was ...


ABTJanuary 2, 2025Abbott Laboratories' Fundamental Strengths Signal Future Market Correction: Stocks Prognosis  ~1 min.

Abbott Laboratories, a global healthcare company, has lately witnessed a decline in its stock performance....


BMYJanuary 4, 2025Bristol-Myers Squibb Company to Expand its Healthcare Offerings at J.P. Morgan Conference  ~1 min.

Bristol-Myers Squibb Company (BMY) is set to present at J.P. Morgan's 43rd Annual Healthcare Conference, showcasing its latest advancements and achievements in the pharmaceutical industry....


ABTJanuary 2, 2025Abbott Laboratories: A Promising Stock with Strong Fundamentals  ~2 min.

Abbott Laboratories (NYSE:ABT) is catching the attention of investors, including Diamond Hill Capital, as one of their top stock picks....


MRKJanuary 1, 2025Merck & Co., Inc. Shows Resilience With Strong Fundamentals  ~2 min.

Despite recent market weakness, pharmaceutical giant Merck & Co., Inc. (NYSE: MRK) remains a strong investment opportunity....


BMYJanuary 10, 2025Bristol Myers Squibb Company: A Leader in the Pharmaceutical Industry  ~2 min.

Bristol Myers Squibb Company (BMY) is a renowned pharmaceutical company that continues to make waves in the industry....